"Designing Growth Strategies is in our DNA"
Urinary retention is the inability to empty the urinary bladder completely and is classified among two types i.e. acute and chronic. Acute urinary retention occurs suddenly and last for a short period of time. However, it is a potentially life threatnening condition and requires immediately an emergency treatment. On other hand, chronic urinary retention can persists for a longer period of time. In most cases, patients suffering from chronic condition are able to urinate, but cannot empty their bladder completely. The urinary retention is caused by obstruction in flow of urine due to conditions like urinary tract stones, urethral stricture, prostate cancer, inflammation of urethra, etc. This disorder affects both men and women but, it tends to occur more frequently in men due to aging. According to a study published in Ethopian Journal of Health Science, urinary retention is 10 times more common in male population than in female population worldwide.
Key Market Driver -
Increasing prevalence of BPH and postoperative urinary retention
Key Market Restraint -
Availability of alternate treatment options
Globally, the urinary retention drugs market is being driven by the rising incidence of post-operative urinary retention, increasing prevalence of benign prostatic hyperplasia and availability of drugs for the treatment of the condition in the market. For instamnce, according to the American Academy of Family Physicians, approximately 250,000 surgical procedures are performed for treating patients suffering from benign prostatic hyperplasia each year in U.S. Thus, is expected to fuel the demand of urinary retention drugs for treatment of patients with BPH during the forecast period.
However, presence of alternative treatment options like catheters, urethral dilation and stents are the some of the major factors that may inhibit the growth of global urinary retention drugs market during the forecast period.
By drug class, the global urinary retention drugs market is segmented into alpha blockers, 5-alpha reductase inhibitors and others. In terms of application, the market is categorized into acute urinary retention and chronic urinary retention. Based on distribution channel, the market is segmented into retail pharmacy, hospital pharmacy and online pharmacy.
From a geographical standpoint, the global market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Key Players Covered:
The major companies in the global urinary retention drugs market report includes Sanofi, Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., GlaxoSmithKline plc., Eli Lilly and Company and others.
The global urinary retention drugs market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America followed by Europe dominated the global market owing to the increasing prevalence of urinary retention, higher diagnosis rate, and high awareness among patient population towards available treatment options. For instance, according to American Academy of Family Physicians, the annual incidence rate of urinary retention in the U.S is around 4.5 to 6.8 per 1,000 men.
To gain extensive insights into the market, Request for Customization
However, increasing patient pool suffering from urinary retention and BPH in Asia Pacific along with increasing awareness among general population towards treatment options for the condition, and increasing diagnosis and treatment rates, is anticipated to fuel the demand of urinary retention drugs market in this region. On other hand, Latin America and Middle East & Africa are projected to register a moderate CAGR during the forecast period.
By Drug Class
By Distribution Channel
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry